Haohai life science: intraocular cross-linked sodium hyaluronate gel product obtains medical device registration certificate

On March 16, Haohai Life Sciences announced that its wholly-owned subsidiary Hesheng Biotechnology has recently received the "Medical Device Registration Certificate of the People's Republic of China" issued by the National Medical Products Administration for its intraocular cross-linked hyaluronic acid sodium gel product. This product uses innovative molecular linear rearrangement cross-linking patented technology and is used for the treatment of macular hole-related retinal detachment. It is suitable for closure of macular hole-related rifts and is the first product in the company's retinal treatment field.